Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 291

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 291
---
167 Anti-Takeover Provisions Section 203 of the Delaware General Corporation Law We are subject to Section 203 of the DGCL, which generally prohibits a publicly held Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:

| ● | before such date, the board of directors of the corporation approved                                                    
 either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; |

| ● | upon completion of the transaction that resulted in the stockholder                                                                   
 becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding  
 at the time the transaction began, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting 
 stock owned by the interested stockholder, those shares owned (1) by persons who are directors and also officers and (2) employee     
 stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan  
 will be tendered in a tender or exchange offer; or                                                                                    |

| ● | on or after such date, the business combination is approved by the                                                                    
 board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative 
 vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.                             |

In general, Section 203 defines a “business combination” to include the following:

| ● | any merger or consolidation involving the corporation and the interested 
 stockholder;                                                             |

| ● | any sale, transfer, pledge or other disposition of 10% or more of the 
 assets of the corporation involving the interested stockholder;       |

| ● | subject to certain exceptions, any transaction that results in the                                     
 issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; |

| ● | any transaction involving the corporation that has the effect of increasing                                                      
 the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; 
 or                                                                                                                               |

| ● | the receipt by the interested stockholder of the benefit of any loans,                   
 advances, guarantees, pledges or other financial benefits by or through the corporation. |

In general, Section 203 defines an “interested stockholder” as an entity or person who,